» Articles » PMID: 16185742

Studies Using a Viral Challenge and CD8 T Cell Depletions on the Roles of Cellular and Humoral Immunity in the Control of an SHIV-89.6P Challenge in DNA/MVA-vaccinated Macaques

Overview
Journal Virology
Specialty Microbiology
Date 2005 Sep 28
PMID 16185742
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Here, we study immune responses in four DNA/MVA-vaccinated macaques following an SHIV-89.6P challenge and a subsequent CD8 cell depletion. Both post-challenge and post-depletion peaks of viremia contracted with the expansion, or re-emergence, of CD8 T cells. Post-depletion, CD8 cells expanded in the presence of higher levels of neutralizing Ab and CD4 help than post-challenge and had superior maturational characteristics as measured by expression of the anti-apoptotic protein Bcl-2, the IL-7 receptor CD127 and co-production of IFN-gamma and IL-2. Pre-challenge and pre-depletion titers of neutralizing Ab correlated inversely with peaks of viremia and directly with peaks for anti-viral CD4 cells. Thus, our results reveal CD8 cells playing a central role, and neutralizing Ab, a supporting role in SHIV-89.6P control. They also suggest a dynamic relationship between neutralizing Ab, antigen load and anti-viral CD4 cells in the maturation of high-quality anti-viral CD8 T cells.

Citing Articles

Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection.

Symmonds J, Gaufin T, Xu C, Raehtz K, Ribeiro R, Pandrea I Viruses. 2024; 16(6.

PMID: 38932264 PMC: 11209256. DOI: 10.3390/v16060972.


Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B.

Perez P, Marin M, Lazaro-Frias A, Sorzano C, Gomez C, Esteban M Vaccines (Basel). 2020; 8(1).

PMID: 32041218 PMC: 7158668. DOI: 10.3390/vaccines8010070.


An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design.

Perez P, Marin M, Lazaro-Frias A, Sorzano C, Di Pilato M, Gomez C Vaccines (Basel). 2019; 7(4).

PMID: 31817622 PMC: 6963416. DOI: 10.3390/vaccines7040208.


The dynamics of simian immunodeficiency virus after depletion of CD8+ cells.

Cardozo E, Apetrei C, Pandrea I, Ribeiro R Immunol Rev. 2018; 285(1):26-37.

PMID: 30129200 PMC: 6352983. DOI: 10.1111/imr.12691.


DNA/MVA Vaccines for HIV/AIDS.

Iyer S, Amara R Vaccines (Basel). 2015; 2(1):160-78.

PMID: 26344473 PMC: 4494194. DOI: 10.3390/vaccines2010160.